Skip to main content

Table 5 Multivariate analysis of factors associated with disease-free survival in patients with Siewert type II/III AEG

From: Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data

Variable

Training cohort (n = 203)

Validation-1 cohort (n = 88)

Validation-2 cohort (n = 105)

HR (95%CI)

P

HR (95%CI)

P

HR (95%CI)

P

Blood transfusion (vs. No)

NA

 

NA

 

NA

 

Organ invasion (vs. Absence)

1.612 (1.074–2.422)

0.021

NA

 

NA

 

Serosal infiltration (vs. S0)

NA

 

NA

 

1.894 (1.348–2.660)

< 0.001

Borrmann type (vs. I)

NA

 

NA

 

NA

 

pTNM stage (vs. I-II)

NA

 

NA

 

NA

 

Grade of differentiation (vs. Well)

NA

 

NA

 

NA

 

PLNa

NA

 

NA

 

1.058 (1.032–1.085)

< 0.001

LNRa

NA

 

NA

 

NA

 

LODDSa

1.408 (1.265–1.568)

< 0.001

1.558 (1.249–1.944)

< 0.001

NA

 

PLT (vs. < 229)

NA

 

0.458 (0.236–0.889)

0.021

NA

 

ALB (vs. < 39.4)

NA

 

NA

 

NA

 

CA-125 (vs. < 9.70)

NA

 

NA

 

NA

 
  1. Abbreviations: ALB albumin, CA125 cancer antigen 125, CI confidence interval, HR hazard ratio, LNR lymph node ratio, LODDS log odds of positive lymph node, NA not available, PLN positive lymph node, PLT platelet, pTNM pathological tumor node metastasis
  2. aContinuous variables